yxhealth.com |
The most popular medications for the
treatment of anxiety are the newest class of antidepressants, the SSRIs—Prozac,
Zoloft, Paxil, Lexapro, and Celexa. Some of the non-SSRI antidepressants (for
instance, Effexor) are also promising.
Since the 1960s, the stand-by
medicines for anxiety have been the benzodiazepines, known by names such as
Valium, Librium, Ativan, Xanax, and Klonopin. They are quite effective and work
quickly. They can also be sedating and are often used to help with insomnia.
The biggest disadvantage of these drugs is that some people can become
psychologically and/or physiologically dependent on them. Sometimes, a person
may get a “buzz” from one of these drugs and subsequently abuse it like alcohol
or other intoxicating substances. If a person becomes physiologically addicted,
sudden withdrawal has been known to lead to seizures and even death. A subtler
side effect of these drugs is a very slight loss of memory.
Unlike the benzodiazepines, the SSRIs
were designed to treat depression. However, abundant research and clinical
practice have shown that they are also effective in combating many forms of
anxiety. Today, SSRIs are considered the first-line medication treatment for
anxiety. Whereas SSRIs take longer to work—sometimes several weeks—they don't
lead to marked physiological dependence. Sudden discontinuation of some SSRIs
is associated with uncomfortable withdrawal-like symptoms, although rarely
associated with seizures or death. Additionally, SSRIs do not produce an
intoxicated feeling, and they generally do not impair memory. Unfortunately,
SSRIs are usually more expensive because most of the patents on these drugs
have not expired. Older antidepressants, such as tricyclics and monoamine
oxidase inhibitors, can be effective in treating anxiety and are often less
expensive. The downside is that they are loaded with side effects and are less
safe than the SSRIs.
Source: The Anxiety Answer Book by: Laurie A. Helgoe, PhD, Laura R. Wilhelm, PhD, Martin J. Kommor, MD
No comments:
Post a Comment